Business Wire

IL-WEBER

16.5.2024 16:01:31 CEST | Business Wire | Press release

Share
Weber LUMIN Electric Grill Wins Prestigious Red Dot Award for Product Design

Weber LLC, the global leader in outdoor cooking innovation, technology, and products, announced today its LUMIN electric grill received a Red Dot Award in the Red Dot Award: Product Design 2024 competition. The Red Dot Design Award, established in 1955, is one of the world’s largest and most prestigious design competitions, receiving more than 20,000 annual submissions from approximately 60 countries worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240516349562/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

The Weber LUMIN electric grill received a Red Dot Award in the Red Dot Award: Product Design 2024 competition. (Photo: Business Wire)

The Weber LUMIN electric grill, featuring a sleek, space-efficient, contemporary silhouette, received the Red Dot Award for its innovative and high-quality design. It is an ideal grill for outdoor cooks with limited space who desire eco-conscious fuel choices, or who live in a location where other forms of grilling are not permitted.

ABOUT THE LUMIN ELECTRIC GRILL

The LUMIN electric grill, introduced in 2023, is a highly versatile, multifunctional product. Its ultra-modern, space-efficient design makes it ideal for smaller outdoor areas such as balconies and terraces.

To create a “next-level” electric cooking experience, Weber product experts engineered this first-of-its-kind grill to:

  • Reach high heat temperatures of more than 600°F/315°C so that cooks can achieve that mouthwatering, authentically grilled flavor they have come to love with Weber products; owners can reach high heat-searing temperatures within 15 minutes.
  • Infuse vegetables and proteins with rich, smokey tastes through a unique smoke mode.
  • Steam vegetables, braise sausages, and keep cooked food warm via different cook settings and specially designed accessories.
  • Thaw frozen foods directly on the grill while it preheats to save time and simplify mealtime.
  • Make clean-up easy with a front-access grease tray and dishwasher-friendly, porcelain-enamel cast iron cooking grates.

The LUMIN electric grill also features a porcelain-enamel steel lid and cookbox for superior durability and long-term corrosion resistance.

The LUMIN electric grill is available for purchase on weber.com and from retail partners across the Americas and Europe. Outdoor cooks can select from full-size or compact models and a variety of vibrant colors, including Ice Blue, Deep Ocean Blue, Golden Yellow, Seafoam Green, Crimson, and timeless Black. Available models and colors vary by geographic region.

ABOUT RED DOT DESIGN AWARDS

Every year, the renowned Red Dot Award: Product Design honors products that impress with their exceptionally high design quality. The award is based on the decision of the Red Dot jury, which consists of 39 experts from 20 countries on four continents. The experts assess the submissions based on the four basic principles of good design: the quality of function, the quality of seduction, the quality of use and the quality of responsibility.

ABOUT WEBER LLC

Weber LLC, headquartered in Palatine, Ill., is the world’s leading barbecue brand. The Company’s founder George Stephen, Sr., established the outdoor cooking category when he invented the original kettle charcoal grill more than 70 years ago. Weber offers a comprehensive, innovative product portfolio, including charcoal, gas, pellet, electric grills, smokers, griddles and accessories, designed to bring people together to create amazing memories and delicious food. Weber offers its products, services and experiences to a passionate community of millions across 78 countries.

WEBER and LUMIN are registered U.S. and EU trademarks owned by Weber-Stephen Products LLC. WEBER and LUMIN are also the subject of registrations or pending applications in other countries.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240516349562/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release

Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L

2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release

“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release

Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies

FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release

Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin

DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved7.5.2026 11:21:00 CEST | Press release

Poster presented at ESMO Breast Cancer 2026: Exploring health policy and real-world treatment strategies for early-stage HER2-positive breast cancer across Europe. The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of its recruitment target, marking a pivotal moment on the path toward to transforming HER2-positive BC treatment. About the DEFINITIVE Project The DEFINITIVE project is a 5-year, prospective, open-label, randomised, two-arm phase III international clinical trial conducted across 44 centres in 7 European member states and associated countries. The trial aims to demonstrat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye